Table III.
Relationships between expression level of AMPD1 and clinicopathological features in PTC patients.
Clinical pathological features | Expression level of AMPD1 | P-value |
---|---|---|
Age/years | 0.059 | |
≥45 | 2.15 (1.65–3.03) | |
<45 | 3.81 (1.25–2.96) | |
Sex | 0.751 | |
Male | 3.67 (1.86–2.55) | |
Female | 3.11 (1.57–2.67) | |
Tumor diameter | 0.045 | |
≥20 mm | 2.01 (1.29–2.59) | |
<20 mm | 3.54 (1.89–3.09) | |
Lymph node metastasis | 0.135 | |
Yes | 2.39 (1.48–3.21) | |
No | 3.18 (1.80–2.67) | |
TNM staging | 0.017 | |
I–II | 3.44 (1.36–3.54) | |
III–IV | 1.87 (1.22–2.57) | |
Number of lesions | 0.074 | |
Single | 2.16 (1.69–3.49) | |
Multiple | 1.54 (2.19–3.56) |